Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 175 participants.
Also called NCT05164107
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 175 participants
- Sponsor
- Registry
-
NCT05164107
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia
- Registry status
- Recruiting
Technical summary
Registry record NCT05164107. Allocation not applicable; no masking; primary purpose other. Start 2021-12-08 (actual); primary completion 2027-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
- Acronym
- PULSE-EU
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Globe Mapping and Pulsed Field Ablation System (Globe PF System)
- Lead sponsor
- Kardium Inc.
Record details
- Record id
cardio:ct-nct05164107- Content hash
250b43366bb7026147a8054b699797d96a71f4381826d3648f10c6512e5c9713